CSB 2.012 NoteCSB 2.81 Addition of brorphine to schedule I. Section 961.14 (2) (et), Stats., is created to read: CSB 2.012 Note961.14 (2) (et) Brorphine;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register May 2021 No. 785, eff. 4-26-21; correction made under s. 35.17, Stats., Register May 2021 No. 785; CR 22-016: cr. Register June 2023 No. 810, eff. 7-1-23; correction made under s. 35.17, Stats., Register June 2023 No. 810. CSB 2.012 NoteCSB 2.82 Addition of Serdexmethylphenidate to schedule IV. Section 961.20 (2m) (em), Stats., is created to read: CSB 2.012 Note961.20 (2m) (em) Serdexmethylphenidate.
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-12-21; CR 22-032: cr. Register June 2023 No. 810, eff. 7-1-23. CSB 2.012 NoteCSB 2.83 Addition of ten (10) fentanyl-related substances to schedule I. Section 961.14 (2) (nd) 21., 22., 23., 24., 25., 26., 27., 28., 29., and 30., Stats., is created to read: CSB 2.012 Note961.14 (2) (nd) 21. N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide (2’-fluoro ortho-fluorofentanyl; 2’-fluoro 2-fluorofentanyl);
CSB 2.012 Note22. N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide (4’-methyl acetyl fentanyl);
CSB 2.012 Note23. N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide (β’-phenyl fentanyl; beta’-Phenyl fentanyl; 3-phenylpropanoyl fentanyl);
CSB 2.012 Note24. N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide (β-methyl fentanyl);
CSB 2.012 Note25. N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide (ortho-fluorobutyryl fentanyl; 2-fluorobutyryl fentanyl);
CSB 2.012 Note26. N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl acetylfentanyl; 2-methyl acetylfentanyl);
CSB 2.012 Note27. 2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide (ortho-methyl methoxyacetylfentanyl; 2-methyl methoxyacetyl fentanyl);
CSB 2.012 Note28. N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide (para-methylfentanyl; 4-methylfentanyl);
CSB 2.012 Note29. N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide (phenyl fentanyl; benzoyl fentanyl);
CSB 2.012 Note30. N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide (thiofuranyl fentanyl; 2-thiofuranyl fentanyl; thiophene fentanyl).
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-19-21; correction made under s. 35.17, Stats., Register July 2021 No. 787; CR 22-033: cr. Register June 2023 No. 810, eff. 7-1-23. CSB 2.012 NoteCSB 2.84 Addition of alfaxalone to schedule IV. (1) Section 961.20 (2) (a), Stat., is repealed and recreated to read:
CSB 2.012 Note961.20 (2) (a) Alfaxalone;
CSB 2.012 Note961.20 (2) (ak) Alprazolam;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-19-21; correction in numbering made under s. 13.92 (4) (b) 1, Stats., and correction made under s. 35.17, Stats., Register July 2021 No. 787; CR 22-034: cr. Register June 2023 No. 810, eff. 7-1-23; correction in numbering made under s. 13.92 (4) (b) 1, Stats., and correction made under s. 35.17, Stats., Register June 2023 No. 810. CSB 2.012 NoteCSB 2.85 Excluding 6-beta-naltrexol from schedule II. Section 961.16 (2) (a), Stats., is amended to read: CSB 2.012 Note961.16 (2) (a) Opium and substances derived from opium, and any salt, compound, derivative or preparation of opium or substances derived from opium. Apomorphine, dextrorphan, nalbuphine, butorphanol, naldemedine, nalmefene, naloxegol, naloxone, 6-beta-naltrexol, and naltrexone and their respective salts and the isoquinoline alkaloids of opium and their respective salts are excluded from this paragraph. The following substances, and any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation, are included in this paragraph:
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-19-21; correction made under s. 35.17, Stats., Register July 2021 No. 787; CR 22-035: cr. Register June 2023 No. 810, eff. 7-1-23. CSB 2.012 NoteCSB 2.86 Addition of fospropofol to schedule IV. Section 961.20 (2) (en), Stats., is created to read: CSB 2.012 Note961.20 (2) (en) Fospropofol;
CSB 2.012 HistoryHistory: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7-19-21; correction made under s. 35.17, Stats., Register July 2021 No. 787; CR 22-036: cr. Register June 2023 No. 810, eff. 7-1-23; correction made under s. 35.17, Stats., Register June 2023 No. 810.